Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Gerber

Showing results (11-20 of 103) with videos related to

Pageof 11
Sort By:
Molecular Immunology|October 12, 2014
Preclinical and clinical development of inotuzumab-ozogamicin in hematological malignanciesBoris Shor, Hans-Peter Gerber, Puja Sapra
Mabs|July 6, 2023
Therapeutic index improvement of antibody-drug conjugatesHans-Peter Gerber, Sanjeev Gangwar, Alison Betts
Molecular Cancer Therapeutics|October 27, 2016
Mechanisms of Resistance to Antibody-Drug ConjugatesFrank Loganzo, Matthew Sung, Hans-Peter Gerber
Biochemical Pharmacology|August 4, 2012
Advances in bispecific biotherapeutics for the treatment of cancerChad May, Puja Sapra, Hans-Peter Gerber
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|December 25, 2009
Targeting inflammatory cells to improve anti-VEGF therapies in oncologyHans-Peter Gerber, Ezogelin Olazoglu, Iqbal S Grewal
Biochemical Pharmacology|December 22, 2015
Combining antibody-drug conjugates and immune-mediated cancer therapy: What to expect?Hans-Peter Gerber, Puja Sapra, Frank Loganzo, et al.
Mabs|January 15, 2010
Antibody drug-conjugates targeting the tumor vasculature: Current and future developmentsHans-Peter Gerber, Peter D Senter, Iqbal S Grewal
Biochemical Pharmacology|June 21, 2014
Advances in patient-derived tumor xenografts: from target identification to predicting clinical response rates in oncologyEdward Rosfjord, Judy Lucas, Gang Li, et al.
Natural Product Reports|March 26, 2013
The antibody-drug conjugate: an enabling modality for natural product-based cancer therapeuticsHans-Peter Gerber, Frank E Koehn, Robert T Abraham
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|February 29, 2016
Weight loss before gastric bypass and postoperative weight change: data from the Scandinavian Obesity Registry (SOReg)Peter Gerber, Claes Anderin, Ulf O Gustafsson, et al.
Pageof 11

Showing results (11-20 of 103) with videos related to

Sort By:
Pageof 11
Molecular Immunology|October 12, 2014
Preclinical and clinical development of inotuzumab-ozogamicin in hematological malignanciesBoris Shor, Hans-Peter Gerber, Puja Sapra
Mabs|July 6, 2023
Therapeutic index improvement of antibody-drug conjugatesHans-Peter Gerber, Sanjeev Gangwar, Alison Betts
Molecular Cancer Therapeutics|October 27, 2016
Mechanisms of Resistance to Antibody-Drug ConjugatesFrank Loganzo, Matthew Sung, Hans-Peter Gerber
Biochemical Pharmacology|August 4, 2012
Advances in bispecific biotherapeutics for the treatment of cancerChad May, Puja Sapra, Hans-Peter Gerber
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|December 25, 2009
Targeting inflammatory cells to improve anti-VEGF therapies in oncologyHans-Peter Gerber, Ezogelin Olazoglu, Iqbal S Grewal
Biochemical Pharmacology|December 22, 2015
Combining antibody-drug conjugates and immune-mediated cancer therapy: What to expect?Hans-Peter Gerber, Puja Sapra, Frank Loganzo, et al.
Mabs|January 15, 2010
Antibody drug-conjugates targeting the tumor vasculature: Current and future developmentsHans-Peter Gerber, Peter D Senter, Iqbal S Grewal
Biochemical Pharmacology|June 21, 2014
Advances in patient-derived tumor xenografts: from target identification to predicting clinical response rates in oncologyEdward Rosfjord, Judy Lucas, Gang Li, et al.
Natural Product Reports|March 26, 2013
The antibody-drug conjugate: an enabling modality for natural product-based cancer therapeuticsHans-Peter Gerber, Frank E Koehn, Robert T Abraham
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|February 29, 2016
Weight loss before gastric bypass and postoperative weight change: data from the Scandinavian Obesity Registry (SOReg)Peter Gerber, Claes Anderin, Ulf O Gustafsson, et al.
Pageof 11